NCT04183166TG4050Mayo ClinicHNSCCSouth Central - Oxford
…Background In the phase I trial TG4050.02 ( NCT04183166) evaluating TG4050 in resected, locally advanced HNSCC patients…
5,089articles mentioning funders
9,137funder mentions
3,238distinct funders extracted
0%of mentions human-reviewed
All extracted funders
Showing 2,401–2,460 of 3,238, ordered by supporting articles. Choose a funder to see its evidence.
National Health Service system1National Health Service-approved1National Health Service/Health Research Authority1National Health and Medical Research Council1National Immunisation Technical Advisory Groups1National Institute for Health and Care Excellence-approved1National Institute for Health and Care Research Health Technology Assessment programme1National Institute for Health and Care Research RfPB grant1National Institute for Health and Disability Insurance1National Institute of Health and Care Excellence1National Institute of Health and Care Research1National Institute of Health funding1National Institute of Mental Health1National Institute on Drug Abuse1National Institutes of Health Office of Dietary Supplements1National League for Nursing1National Lottery Community Fund1National Malaria Control Programmes1National Medical & Research Register1National Medical Product Authority1National Medical Products Administration1National Paralympic Committees1National Patient Safety Agency1National Pediatric Cancer Foundation1National Pharmacovigilance Network1National PrEP Pilot Program1National Research Agency1National Research Council1National Research Council of Thailand1National Research Ethics Service1National Research, Development and Innovation Fund of Hungary1National Resource Fund1National Union of Mineworkers1National University of Malaysia Ethics Committee1National Violent Death Reporting System1National consumer organisations1Nationwide Readmissions Database1Naval Servicewomen’s Network1Navigate BioPharma1Navy1Nelson Family Transplant Innovation Award1Neonatal Transport Group1Nepal Paediatric Society1Nepal Red Cross Society1Netherlands Central Committee on Research Involving Human Subjects1Network for Safety in Regional Anesthesia and Acute Pain Therapy registry1Neurological Alliance1Neurosurgery Research & Education Foundation1New Economics Foundation1New South Wales State Ministry of Health1New Zealand Central Health and Disability Ethics Committee1New Zealand national ACP programme1Newcastle upon Tyne Hospitals NHS Foundation Trust1Newfoundland and Labrador Health Research Ethics Board1Neyveli Lignite Corporation1Ngāi Tahu Research Consultation Committee1NielsenIQ1Nigerian Ministry of Health1Nihon Kohden Corporation1No. 2022-0691
Articles mentioning funders
5,089 articles · page 330 of 425NCT04162015nivolumabDiffuse pleural mesotheliomapemetrexedcisplatincarboplatinplatinumP/D
…exed prior to P/D (2 cycles) for patients with resectable DPM ( NCT04162015).Methods To comprehensively assess tumor and immune microenviro…
Bristol-Myers Squibbneoadjuvant immunotherapynivolumabEGFR-mutant NSCLCchemotherapyCTONG1104
…and families involved in this study. This work was supported by Bristol-Myers Squibb, Guangdong Provincial Key Lab of Translational Medicine in Lung…
Foundation for the National Institutes of Health, Inc.CAN-2409docetaxelNSCLCsacituzumab govitecanvalacyclovir
…oject was made possible through funding support provided to the Foundation for the National Institutes of Health, Inc. (FNIH) by: AbbVie Inc., Amgen Inc., Boehringer-Ingelheim Pharma…
AstraZenecadurvalumabcapivasertibDurvaolaparibOlaCaprelapse/refractory solid cancers
…ing macrophages and stromal cells are underway.Acknowledgements AstraZeneca’s support is gratefully acknowledgedTrial Registration NCT03772…
Astellas Pharma Inc.ASP1012la/m solid tumorsadvanced solid tumorsOxford PharmaGenesis Inc.
…uding 3×10 9 pfu/dose.Acknowledgements This study was funded by Astellas Pharma Inc. Medical writing support, conducted in accordance with Good Publ…
IRB00115160cemiplimabEmory Universitymetastatic cutaneous squamous cell carcinoma (CSCC)
…proval The study was approved by the Emory IRB (approval number IRB00115160) and participants gave informed consent to take part in this st…
FDAMitazalimabmFOLFIRINOX
… Journal for ImmunoTherapy of Cancer 2024;12(Suppl 2):A677–A678.FDA. Optimizing the dose of human prescription drugs and biological…
FDAEVOLVE104EIU-104101urothelial carcinomasquamous cell carcinomasCohort BCohort AEVOLVE TCEstransitional cell carcinomas of the urinary tractlocally advanced or metastatic solid tumors
…g.Ethics Approval Study EIU-104101 is currently under review by FDA and will only begin enrollment upon clearance from relevant hea…
American Surgical Association Research AwardAppendiceal cancerMD Anderson Cancer CenterBarnes-Jewish HospitalpaclitaxelUniversity of Texas MD Anderson Cancer Centercolorectal cancerWashington University Institutional Review Board
…cy.Acknowledgements This work was supported by funding from the American Surgical Association Research Award (Dr. Beth A. Helmink), NIH grant R37AI049653 (Dr. Gwendalyn J. …
PHASE ONE FoundationECOG Performance StatusDana-Farber Cancer InstituteIL-12myeloid leukemiaIL-15IL-18PROCpembrolizumabDana-Farber/Harvard Cancer Center+6 more
…uable. The authors are deeply grateful for funding support from PHASE ONE Foundation and from Pan-Mass Challenge Team Ovarian Cancer.References Disi…
Mount Sinai PPHS IRBHNSCCimmunotherapyMount Sinai Institutional BiorepositoryHead and neck squamous cell carcinoma (HNSCC)
…drivers of immunotherapy resistance among HNSCC.Ethics Approval Mount Sinai PPHS IRB approved STUDY-21-01683…